
Jaducef TZ 250mg/31.25mg Injection
Marketer
Panm Labs India
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Jaducef TZ 250mg/31.25mg Injection
Cefixime and Azithromycin Injection (250mg/31.25mg), a dual-action antibiotic, combats diverse bacterial infections. Its mechanism halts microbial proliferation and infection spread. Administration must be solely by a medical professional; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate medical help for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your doctor of all current medications, and pregnant or breastfeeding individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Jaducef TZ 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Jaducef TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Jaducef TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Jaducef TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Jaducef TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Jaducef TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Jaducef TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, complements this action by counteracting bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Jaducef TZ 250mg/31.25mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Jaducef TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; however, data from human trials remain scarce.
Breast feedingCAUTION
Administering Jaducef TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until maternal therapy concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Jaducef TZ 250mg/31.25mg Injection could lead to drowsiness, impaired vision, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Jaducef TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Jaducef TZ 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Jaducef TZ 250mg/31.25mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Jaducef TZ 250mg/31.25mg Injection :
Omit a scheduled Jaducef TZ 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Jaducef TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
